×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Matthew W. Foehr

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOAug 26, 2025Award/Grant$1.85540,540999,9994,341,987Aug 26, 2025, 04:02 PM
VKTXViking Therapeutics, Inc.Matthew W. FoehrDirectorApr 11, 2025Option/RSU Exercise$8.0020,786166,288132,036Apr 14, 2025, 07:26 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOApr 07, 2025Option/RSU Exercise-36,458-3,815,618Apr 07, 2025, 08:17 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOApr 07, 2025Sale$2.0019,38238,7643,796,236Apr 07, 2025, 08:17 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOFeb 19, 2025Sale$3.6719,52271,6463,779,160Feb 19, 2025, 08:51 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOFeb 15, 2025Option/RSU Exercise-26,549-3,776,188Feb 19, 2025, 08:51 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOFeb 16, 2025Option/RSU Exercise-36,458-3,812,646Feb 19, 2025, 08:51 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOFeb 18, 2025Sale$3.6813,96451,3883,798,682Feb 19, 2025, 08:51 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOJan 21, 2025Sale$3.2441,811135,4683,749,639Jan 22, 2025, 05:40 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEODec 09, 2024Sale$4.1313,63456,3083,714,447Dec 10, 2024, 04:44 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEODec 07, 2024Option/RSU Exercise-26,555-3,728,081Dec 10, 2024, 04:44 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEONov 25, 2024Option/RSU Exercise$3.7399,434370,7023,698,600Nov 26, 2024, 04:41 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOJun 27, 2024Option/RSU Exercise$3.7359,659222,4163,599,166Jun 27, 2024, 04:55 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOMay 24, 2024Buy$4.42240,0001,059,8403,536,665May 28, 2024, 05:55 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOApr 07, 2024Option/RSU Exercise-36,458-3,188,874Apr 09, 2024, 06:38 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOApr 07, 2024Tax Payment (Shares)$5.3118,47798,1133,170,397Apr 09, 2024, 06:38 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOMar 27, 2024Option/RSU Exercise$3.72243,613907,0233,152,416Mar 29, 2024, 04:52 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOMar 22, 2024Buy$5.19225,0001,167,7502,908,803Mar 25, 2024, 07:07 AM
OABIOmniAb, Inc.Matthew W. FoehrChief Executive OfficerFeb 15, 2024Tax Payment (Shares)$5.5418,919104,8112,683,803Feb 20, 2024, 06:22 PM
OABIOmniAb, Inc.Matthew W. FoehrChief Executive OfficerFeb 15, 2024Option/RSU Exercise-37,328-2,697,263Feb 20, 2024, 06:22 PM
OABIOmniAb, Inc.Matthew W. FoehrChief Executive OfficerJan 02, 2024Option/RSU Exercise-33,173-2,678,615Jan 03, 2024, 05:42 PM
OABIOmniAb, Inc.Matthew W. FoehrChief Executive OfficerJan 02, 2024Tax Payment (Shares)$6.2513,22182,6312,665,394Jan 03, 2024, 05:42 PM
OABIOmniAb, Inc.Matthew W. FoehrChief Executive OfficerDec 12, 2023Buy$5.05200,0001,010,0002,645,442Dec 13, 2023, 03:25 PM
OABIOmniAb, Inc.Matthew W. FoehrChief Executive OfficerDec 07, 2023Tax Payment (Shares)$4.859,18444,5422,445,442Dec 11, 2023, 07:24 PM
OABIOmniAb, Inc.Matthew W. FoehrChief Executive OfficerDec 07, 2023Option/RSU Exercise-26,556-2,454,626Dec 11, 2023, 07:24 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEONov 10, 2023Buy$4.2795,000405,5172,427,919Nov 13, 2023, 08:00 AM
OABIOmniAb, Inc.Matthew W. FoehrPresident and CEOAug 14, 2023Buy$5.4845,000246,6002,332,919Aug 15, 2023, 04:56 PM
OABIOmniAb, Inc.Matthew W. FoehrChief Executive OfficerJun 09, 2023Buy$4.52115,000519,8002,574,009Jun 12, 2023, 04:47 PM
OABIOmniAb, Inc.Matthew W. FoehrChief Executive OfficerMay 12, 2023Buy$3.40440,0001,496,0002,438,414May 15, 2023, 04:02 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident & CEOFeb 15, 2023Tax Payment (Shares)$3.8017,08664,9271,896,941Feb 17, 2023, 07:28 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident & CEODec 28, 2022Tax Payment (Shares)$3.6611,62442,5441,826,460Dec 30, 2022, 05:00 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident & CEODec 12, 2022Buy$3.77150,000564,7651,838,084Dec 14, 2022, 05:00 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident & CEODec 01, 2022Tax Payment (Shares)$3.3517,26657,8411,688,084Dec 05, 2022, 09:36 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident & CEONov 30, 2022Buy$3.39300,0001,016,3401,705,350Dec 01, 2022, 06:00 PM
OABIOmniAb, Inc.Matthew W. FoehrPresident & CEONov 09, 2022Buy$2.76100,000276,1601,405,350Nov 09, 2022, 08:30 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOMay 13, 2022Buy$82.762,500206,910173,354May 13, 2022, 07:05 PM
VKTXViking Therapeutics, Inc.Matthew W. FoehrDirectorMay 02, 2022Buy$2.4745,000111,195111,250May 03, 2022, 04:12 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 15, 2022Tax Payment (Shares)$123.683,546438,569173,166Feb 16, 2022, 08:24 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOJan 26, 2022Tax Payment (Shares)$113.685,125582,610177,588Jan 28, 2022, 08:41 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COONov 11, 2021Option/RSU Exercise$28.5412,188347,818177,685Nov 12, 2021, 04:54 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COONov 11, 2021Sale$163.0211,1601,819,259166,525Nov 12, 2021, 04:54 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOAug 04, 2021Option/RSU Exercise$29.239,982291,745173,195Aug 05, 2021, 04:44 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOAug 04, 2021Sale$109.678,840969,509164,355Aug 05, 2021, 04:44 PM
VKTXViking Therapeutics, Inc.Matthew W. FoehrDirectorJun 10, 2021Buy$5.6920,000113,80066,250Jun 10, 2021, 04:57 PM
VKTXViking Therapeutics, Inc.Matthew W. FoehrDirectorMar 22, 2021ATM/ITM Option Exercise$1.5020,00030,00046,250Mar 25, 2021, 09:30 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 15, 2021Tax Payment (Shares)$172.463,098534,281167,557Feb 18, 2021, 06:28 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 04, 2021Sale$176.8644,5477,878,582168,198Feb 05, 2021, 05:03 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 04, 2021Option/RSU Exercise$23.0745,5471,050,890212,745Feb 05, 2021, 05:03 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOJan 25, 2021Tax Payment (Shares)$156.013,325518,733160,603Jan 27, 2021, 07:03 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOAug 21, 2020Sale$112.887,225815,544155,413Aug 25, 2020, 07:10 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOAug 24, 2020Option/RSU Exercise$21.92781,710155,491Aug 25, 2020, 07:10 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOAug 24, 2020Sale$110.89788,649155,413Aug 25, 2020, 07:10 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOAug 21, 2020Option/RSU Exercise$20.388,015163,338162,638Aug 25, 2020, 07:10 PM
VKTXViking Therapeutics, Inc.Matthew W. FoehrDirectorJun 30, 2020Sale$7.3513,00095,55026,250Jun 30, 2020, 05:54 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 15, 2019Tax Payment (Shares)$120.862,826341,550124,615Apr 24, 2020, 07:23 PM
RTTRRITTER PHARMACEUTICALS INCMatthew W. FoehrDirectorJan 21, 2020Conversion-76,923-100,174Apr 23, 2020, 04:15 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOMar 13, 2020Option/RSU Exercise$21.922,00043,840157,449Mar 13, 2020, 06:33 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 27, 2020Option/RSU Exercise$15.898,931141,941160,968Feb 27, 2020, 08:35 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 27, 2020Sale$110.007,225794,750153,743Feb 27, 2020, 08:35 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 13, 2020Option/RSU Exercise$21.9249610,872148,833Feb 18, 2020, 05:09 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 14, 2020Option/RSU Exercise$14.477,225104,546163,454Feb 18, 2020, 05:09 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 14, 2020Sale$95.847,225692,467156,229Feb 18, 2020, 05:09 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 15, 2020Tax Payment (Shares)$97.232,486241,714155,360Feb 18, 2020, 05:09 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COODec 20, 2019Tax Payment (Shares)$105.873,654386,849148,337Dec 26, 2019, 02:01 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COONov 12, 2019Option/RSU Exercise$21.921,00121,942144,620Nov 13, 2019, 04:07 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOSep 05, 2019Option/RSU Exercise$21.921,00522,030143,619Sep 05, 2019, 07:24 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOAug 12, 2019Option/RSU Exercise$21.921,16325,493142,614Aug 13, 2019, 01:45 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOJun 11, 2019Option/RSU Exercise$21.921,00422,008141,451Jun 12, 2019, 06:50 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOMar 14, 2019Option/RSU Exercise$9.9714,894148,493140,447Mar 15, 2019, 02:00 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOJan 23, 2019Tax Payment (Shares)$111.782,568287,051118,081Jan 25, 2019, 04:31 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COODec 12, 2018Option/RSU Exercise$9.977,99979,750113,387Dec 12, 2018, 05:32 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOOct 01, 2018Option/RSU Exercise$13.8014,088194,457117,388Oct 02, 2018, 06:24 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOOct 01, 2018Sale$273.8812,0003,286,560105,388Oct 02, 2018, 06:24 PM
RTTRRITTER PHARMACEUTICALS INCMatthew W. FoehrDirectorAug 17, 2018Buy$2.0419,75140,29223,251Sep 19, 2018, 02:19 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOSep 04, 2018Option/RSU Exercise$14.1113,044184,049115,300Sep 05, 2018, 08:18 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOSep 04, 2018Sale$255.0112,0003,060,084103,300Sep 05, 2018, 08:18 PM
RTTRRITTER PHARMACEUTICALS INCMatthew W. FoehrDirectorAug 17, 2018Buy$2.0419,75140,29254,751Aug 20, 2018, 05:19 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOMay 10, 2018Sale$167.638,8811,488,687101,201May 11, 2018, 05:32 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOMay 10, 2018Option/RSU Exercise$13.999,936139,026110,082May 11, 2018, 05:32 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOMar 06, 2018Tax Payment (Shares)$165.871,457241,673101,201Mar 06, 2018, 06:36 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 23, 2018Option/RSU Exercise$13.776,44888,785101,279Feb 27, 2018, 06:39 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 23, 2018Sale$152.985,444832,82395,835Feb 27, 2018, 06:39 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 15, 2018Tax Payment (Shares)$157.183,663575,75096,983Feb 16, 2018, 05:39 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COODec 28, 2017Tax Payment (Shares)$138.662,971411,95998,494Dec 29, 2017, 09:17 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOAug 09, 2017Option/RSU Exercise$9.976,95069,292101,020Aug 10, 2017, 06:40 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOAug 09, 2017Sale$127.516,100777,82394,920Aug 10, 2017, 06:40 PM
RTTRRITTER PHARMACEUTICALS INCMatthew W. FoehrDirectorMay 18, 2017Buy$0.6218,00011,15535,000May 18, 2017, 03:39 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOMay 12, 2017Sale$112.195,621630,64892,720May 15, 2017, 07:05 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOMay 15, 2017Option/RSU Exercise$9.972,20021,93494,920May 15, 2017, 07:05 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOMay 12, 2017Option/RSU Exercise$9.975,62156,04198,341May 15, 2017, 07:05 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOMar 02, 2017Option/RSU Exercise$9.976,87968,58497,599Mar 03, 2017, 06:54 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOMar 02, 2017Sale$103.396,879711,21390,720Mar 03, 2017, 06:54 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOMar 03, 2017Option/RSU Exercise$9.972,00019,94092,720Mar 03, 2017, 06:54 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 24, 2017Tax Payment (Shares)$100.382,733274,33983,176Feb 28, 2017, 06:27 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOFeb 15, 2017Tax Payment (Shares)$104.282,367246,83181,395Feb 28, 2017, 06:27 PM
VKTXViking Therapeutics, Inc.Matthew W. FoehrDirectorNov 15, 2016Buy$1.2113,00015,67839,250Nov 15, 2016, 04:34 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOAug 05, 2016Option/RSU Exercise$9.9712,500124,62591,412Aug 09, 2016, 04:58 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOAug 05, 2016Sale$122.1412,5001,526,75078,912Aug 09, 2016, 04:58 PM
LGNDLIGAND PHARMACEUTICALS INCMatthew W. FoehrPresident and COOAug 08, 2016Option/RSU Exercise$9.974,12541,12683,037Aug 09, 2016, 04:58 PM
VKTXViking Therapeutics, Inc.Matthew W. FoehrDirectorApr 13, 2016Buy$1.2420,00024,80026,250Apr 13, 2016, 06:17 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe